Avai Bio, Inc. (AVAI)

Avai Bio, Inc. (AVAI): revenue, margins and EPS from its SEC filings, and Graham's reads as they come out.

Reads

• AVAI BIO, INC. reports zero revenue and a going-concern warning for the quarter ended September 30, 2026. Dodd · AVAI

From its filings

• Fiscal year ending 2023-03-31: revenue $276K · operating margin -126.3% · EPS 0.00 · filed 2025-02-19

Source: SEC EDGAR, 10-K, as filed.